Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Avins A. L., Haber R. J., Hulley S. B. The status of hypertriglyceridemia as a risk factor for coronary heart disease. Clin Lab Med. 1989 Mar;9(1):153–168. [PubMed] [Google Scholar]
- Barrett-Connor E., Bush T. L. Estrogen replacement and coronary heart disease. Cardiovasc Clin. 1989;19(3):159–172. [PubMed] [Google Scholar]
- Canner P. L., Berge K. G., Wenger N. K., Stamler J., Friedman L., Prineas R. J., Friedewald W. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986 Dec;8(6):1245–1255. doi: 10.1016/s0735-1097(86)80293-5. [DOI] [PubMed] [Google Scholar]
- Carlson L. A., Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 1988;223(5):405–418. doi: 10.1111/j.0954-6820.1988.tb15891.x. [DOI] [PubMed] [Google Scholar]
- Garber A. M., Sox H. C., Jr, Littenberg B. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med. 1989 Apr 15;110(8):622–639. doi: 10.7326/0003-4819-110-8-622. [DOI] [PubMed] [Google Scholar]
- Hayward R. S., Steinberg E. P., Ford D. E., Roizen M. F., Roach K. W. Preventive care guidelines: 1991. American College of Physicians. Canadian Task Force on the Periodic Health Examination. United States Preventive Services Task Force. Ann Intern Med. 1991 May 1;114(9):758–783. doi: 10.7326/0003-4819-114-9-758. [DOI] [PubMed] [Google Scholar]
- Hulley S. B., Rosenman R. H., Bawol R. D., Brand R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 1980 Jun 19;302(25):1383–1389. doi: 10.1056/NEJM198006193022503. [DOI] [PubMed] [Google Scholar]
- Levy R. I., Brensike J. F., Epstein S. E., Kelsey S. F., Passamani E. R., Richardson J. M., Loh I. K., Stone N. J., Aldrich R. F., Battaglini J. W. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation. 1984 Feb;69(2):325–337. doi: 10.1161/01.cir.69.2.325. [DOI] [PubMed] [Google Scholar]
- Muldoon M. F., Manuck S. B., Matthews K. A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990 Aug 11;301(6747):309–314. doi: 10.1136/bmj.301.6747.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newman T. B., Browner W. S., Hulley S. B. Childhood cholesterol screening: contraindicated. JAMA. 1992 Jan 1;267(1):100–102. [PubMed] [Google Scholar]
- Oliver M. F. Sounding board. Risks of correcting the risks of coronary disease and stroke with drugs. N Engl J Med. 1982 Feb 4;306(5):297–298. doi: 10.1056/NEJM198202043060511. [DOI] [PubMed] [Google Scholar]
- Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991 Jan;20(1):47–63. doi: 10.1016/0091-7435(91)90006-p. [DOI] [PubMed] [Google Scholar]